Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers

Clinical trial NCT04416568 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04416568
Sponsor: Dana-Farber Cancer Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Rhabdoid Tumor Rhabdoid Tumor of the Kidney Epithelioid Sarcoma Chordoma (Poorly Differentiated or De-differentiated)Atypical Teratoid/Rhabdoid Tumor Other INI1 Negative Tumors (With PI Approval)Other SMARCA4-deficient Malignant Tumors (With PI Approval)

Start date: 2020-08-14
Primary completion: 2025-07-17
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.